To investigate the origin of the vermal tau-PET signal, we conducted an extensive set of analyses, including static and dynamic tau-PET imaging using the second generation radioligand [18F]PI-2620, along with examination of tissue samples from deceased patients with neurodegenerative diseases. Here, MAPT is linked to neurodegenerative disease.